Shares in pharmaceutical companies SURGE after Johnson & Johnson receives opioid crisis fine

Judge Thad Balkman ordered Johnson & Johnson to pay $572m to Oklahoma for their part in the opioid crisis. After the ruling Endo International, Teva Pharmaceutical and Mallinckrodt saw gains.